Mikael von Euler, Charlotta Liljebris, Magnus Brisander, Per Andersson, Hans Lennernäs, Börje Darpö, Leif Stenke. "XS003, an amorphous re-formulation of nilotinib, demonstrates improved dose linearity and minimal food effect, reducing the risk of QT-prolongation at fed conditions." Blood, 2025. doi:10.1182/blood-2025-5547